YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutations.
Clin Transl Med
; 13(2): e1190, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36740402
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Transcription Factors
/
Mesothelioma
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Humans
Language:
En
Journal:
Clin Transl Med
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: